Meyers & Flowers warning: FDA recalls drugs containing valsartan for potential cancer risk, Many common high blood pressure and heart failure medications affected
Meyers & Flowers is warning patients taking heart failure and high blood pressure medications with the active ingredient valsartan about a serious recall linking the medications to a potential cancer risk.
The U.S. Food and Drug Administration (FDA) is voluntarily recalling several drug products containing the active ingredient valsartan, commonly used to treat high blood pressure and heart failure. It has been found the recalled drugs are contaminated with N-nitrosodimethylamine (NDMA). According to the FDA, “NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. The presence of NDMA was unexpected and is thought to be related to changes in the way the active substance was manufactured.”
NDMA is an organic chemical used to make liquid rocket fuel, softeners and lubricants, among other products. Symptoms of exposure to high levels of NDMA may include headaches, fever, nausea, vomiting, and reduced function and damage to the kidneys, liver, and lungs as well as a risk of cancer.
Not all products containing valsartan are being recalled, only products made by specific manufacturers. Valsartan-based medications from Major Pharmaceuticals, Solco Healthcare, and Teva Pharmaceuticals Industries, as well as valsartan/hydrochlorothiazide from Solco and Teva, are currently part of the FDA recall.
In addition to the FDA recall, some 22 other countries issued recalls involving 2,300 valsartan batches sent to Canada, Germany, Finland, Norway, Sweden, Hungary, Spain, the Netherlands, Ireland, Austria, Italy, Bulgaria, Portugal, France, Belgium, Croatia, Poland, Lithuania, Greece, Bosnia and Herzegovina, Bahrain and Malta.
If you or a family member have been taking valsartan-based drugs and have been diagnosed with cancer, you may have legal recourse. Contact the Meyers & Flowers team for more information about the valsartan recall and your legal options. We can be reached at email@example.com, 877-221-2511 or fill in a free case evaluation form here.